학술논문
British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis.
Document Type
Article
Author
Source
Subject
*BIOTHERAPY
*HEPATITIS B
*HEPATITIS C risk factors
*HIV infection risk factors
*INFECTION
*INFECTION risk factors
*RESPIRATORY disease diagnosis
*RITUXIMAB
*RHEUMATOLOGY
*TOCILIZUMAB
*ANTIRHEUMATIC agents
*MEDICAL protocols
*PATIENT education
*PHYSICIAN-patient relations
*RHEUMATOID arthritis
*COMORBIDITY
*TUMOR necrosis factors
*CHEMICAL inhibitors
*DIAGNOSIS
*DISEASE risk factors
*THERAPEUTICS
*SOCIETIES
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1462-0324
Abstract
The article discusses the biologic disease-modifying antirheumatic drug safety guidelines in inflammatory arthritis by the British Society for Rheumatology (BSR). The purpose of the guideline is to offer evidence-based recommendations for the safe use of biologic therapies in adults. Biologic therapies covered by the guideline are shown in a chart. The guideline was commissioned by the BSR Standards, Guidelines and Audit Working Group.